Sagility Q2 FY27 Revenue Up 22.5% to ₹20,321 Million; Acquires Chirok Health
Sagility Limited reported Q2 FY27 revenue of ₹20,321 Million, up 22.5% YoY. Adjusted EBITDA increased 23.0% to ₹5,353 Million. The company acquired Chirok Health LLC for $20 Million to boost its Provider segment. An interim dividend of ₹0.15 per share was declared.
The significant year-on-year revenue and profit growth, coupled with a strategic acquisition that expands the company's service offerings and market reach, indicates a high impact on the company's future performance and market position.
The company reported strong year-on-year growth in revenue and adjusted EBITDA, alongside a strategic acquisition that is expected to accelerate growth. These positive financial and strategic developments contribute to a positive sentiment.
Sagility Limited announced its financial results for the quarter and half-year ended September 30, 2026, alongside an investor presentation scheduled for October 22, 2026. The company reported a 22.5% year-on-year increase in Revenue from Operations to ₹20,321 Million for Q2 FY27, reaching ₹39,956 Million for H1 FY27, a 25.0% YoY growth.
Adjusted EBITDA for Q2 FY27 grew by 23.0% YoY to ₹5,353 Million, with a margin of 26.3%. For H1 FY27, Adjusted EBITDA was ₹10,069 Million, up 25.2% YoY. Adjusted PAT for Q2 FY27 was ₹3,254 Million (up 8.1% YoY), and for H1 FY27, it was ₹5,951 Million (up 18.9% YoY).
Key business insights include 11.9% YoY constant currency organic growth driven by expansion within national payers and mid-market clients. The company secured $40.2 Million in Annual Contract Value (ACV) in Q2 FY27 from existing and new clients, with increasing traction in larger deals. Sagility highlighted growing AI momentum with new SOW wins and production deployments.
Furthermore, Sagility has acquired Chirok Health LLC for $20 Million upfront payment, with contingent consideration up to $12.35 Million. This acquisition aims to accelerate growth in the Provider segment by adding specialized Clinical Documentation Improvement (CDI) and coding capabilities, extending Sagility’s end-to-end RCM offering.
The company also declared an interim dividend of ₹0.15 per share. Sagility received several recognitions, including the Golden Peacock Award for ESG and the 2026 Stratus Awards for Cloud Computing.
What to do with a filing like this
SAGILITY LIMITED filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by SAGILITY LIMITED. Read the original for the full detail.